This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Xsensio Raises $7M Series A,...
Business Series A financing

Xsensio Raises $7M Series A, Partners Texas Instruments

Analysis based on 9 articles · First reported Mar 02, 2026 · Last updated Mar 03, 2026

Sentiment
60
Attention
2
Articles
9
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The successful Series A financing for Xsensio and its collaboration with Texas Instruments are positive for the health tech and semiconductor markets. This event signals growth and innovation in wearable biosensing, potentially leading to new investment opportunities and advancements in patient monitoring.

Biotechnology Semiconductor industry Venture capital
Event Summary

Xsensio, a Swiss deep-tech company, successfully closed a $7M oversubscribed Series A financing round. The round was led by WI Harper Group, with participation from Privilège Ventures, the European Union===European Innovation Council, and private investors. This funding will accelerate the development and clinical validation of Xsensio's Lab-on-Skin wearable biosensing platform. In parallel, Xsensio announced a long-term collaboration with Texas Instruments, a leader in semiconductor technology, to strengthen industrial scalability and integrate CMOS expertise. Esmeralda Megally, CEO of Xsensio, highlighted the pivotal step this marks for continuous biochemical monitoring in clinical environments. Adrian Ionescu, CTO, emphasized the strengthened path to advanced, scalable semiconductor technology. Wilson Wu of WI Harper Group expressed excitement about leading the investment, recognizing Xsensio's progress and market potential. Jaqueline Ruedin Rüsch, Chair of the Board, noted Xsensio's unique position to lead the transformation in real-time biochemical insight.

Key Actions
100 Xsensio closed $7M oversubscribed Series A financing round
90 Xsensio announced long-term collaboration Texas Instruments
90 Texas Instruments entered long-term collaboration Xsensio
80 WI Harper Group led Series A financing round Xsensio
40 Privilège Ventures participated in Series A financing round Xsensio
40 European Union===European Innovation Council participated in Series A financing round Xsensio
Entities Involved
priv
Xsensio
Xsensio successfully closed a $7M oversubscribed Series A financing round, which will accelerate the development and clinical validation of its Lab-on-Skin wearable biosensing platform. This funding, along with a collaboration with Texas Instruments, is expected to strengthen Xsensio's industrial scalability and market position in continuous biochemical monitoring.
Importance 100 Sentiment 70
per
Esmeralda Megally
As CEO of Xsensio, Esmeralda Megally announced the successful Series A financing and emphasized its importance for translating continuous biochemical monitoring into clinical environments. Her leadership is crucial for Xsensio's strategic direction and growth.
Importance 90 Sentiment 60
priv
WI Harper Group
WI Harper Group led the Series A financing round for Xsensio, indicating a strategic investment in the wearable biosensing market. This move positions WI Harper Group as a key supporter of Xsensio's innovative technology.
Importance 80 Sentiment 50
stock
Texas Instruments
Texas Instruments announced a long-term collaboration with Xsensio, providing expertise in CMOS integration, miniaturization, and large-scale manufacturability. This partnership strengthens Texas Instruments' presence in the biosensing systems market.
Importance 70 Sentiment 20
per
Adrian Ionescu
As CTO of Xsensio, Adrian Ionescu highlighted the significance of the collaboration with Texas Instruments for strengthening Xsensio's path to advanced, scalable semiconductor technology. His technical vision is key to the platform's development.
Importance 70 Sentiment 50
per
Wilson Wu
As a Partner at WI Harper Group, Wilson Wu expressed excitement about leading the investment round in Xsensio, recognizing the company's progress and market potential in wearable biosensing. His involvement signifies WI Harper Group's confidence in Xsensio.
Importance 60 Sentiment 40
per
Jaqueline Ruedin Rüsch
As Chair of the Board for Xsensio, Jaqueline Ruedin Rüsch emphasized Xsensio's unique position to lead the transformation in continuous biochemical monitoring. Her perspective underscores the strategic importance of the event.
Importance 50 Sentiment 40
+ 2 more entities View on Dashboard
Relationships
Esmeralda Megally related ↔ Xsensio
Adrian Ionescu related ↔ Xsensio
Wilson Wu related ↔ WI Harper Group
Jaqueline Ruedin Rüsch related ↔ Xsensio
WI Harper Group related ↔ Xsensio
Privilège Ventures related ↔ Xsensio
European Union===European Innovation Council related ↔ Xsensio
Xsensio related ↔ Texas Instruments
WI Harper Group related ↔ Texas Instruments
Esmeralda Megally related ↔ WI Harper Group
+ 4 more relationships View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.